[1] Lioyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation, 2010; 121, e46-e215. doi:  10.1161/CIRCULATIONAHA.109.192667
[2] Doll R, Peto R, Boreham J, et al. Mortality in the relation to smoking: 50 years' observations on the male British doctors. BMJ, 2004; 328, 1519. doi:  10.1136/bmj.38142.554479.AE
[3] Freund KM, Belanger AJ, D'Agostino RB, et al. The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol, 1993; 3, 417-24. doi:  10.1016/1047-2797(93)90070-K
[4] Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation, 1993; 88, 2149-55. doi:  10.1161/01.CIR.88.5.2149
[5] Rosenberg L, Kaufman DW, Helmrich SP, et al. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med, 1985; 13, 1511-4. https://www.ncbi.nlm.nih.gov/pubmed/4069159
[6] Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med, 1990; 322, 213-7. doi:  10.1056/NEJM199001253220401
[7] Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol, 2004; 43, 1731-7. doi:  10.1016/j.jacc.2003.12.047
[8] Benowitz NL. Cigarette smoking and cardiovascular disease: pathophysiology and implication for treatment. Prog Cardiovasc Dis, 2003; 46, 91-111. doi:  10.1016/S0033-0620(03)00087-2
[9] Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ, 1989; 298, 784-8. doi:  10.1136/bmj.298.6676.784
[10] Mjos OD. Lipid effects and smoking. Am Heart J, 1988; 115, 272-5. doi:  10.1016/0002-8703(88)90649-7
[11] Criqui MH, Wallace RB, Heiss G, et al. Cigarette smoking and plasma high-density lipoprotein cholesterol: The Lipid Research Clinics Program Prevalence Study. Circulation, 1980; 62, IV70-6. https://uncch.pure.elsevier.com/en/publications/cigarette-smoking-and-plasma-high-density-lipoprotein-cholesterol
[12] Athyros VG, Katsiki N, Doumas M, et al. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr Med Res Opin, 2013; 29, 1263-74. doi:  10.1185/03007995.2013.827566
[13] Xu RX, Li S, Li XL, et al. High-density lipoprotein subfractions in relation with the severity of coronary artery disease: a Gensini score assessment. J Clin Lipidol, 2015; 9, 26-34. doi:  10.1016/j.jacl.2014.11.003
[14] Martin SS, Khokhar AA, May HT, et al. HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative. Eur Heart J, 2015; 36, 22-30. doi:  10.1093/eurheartj/ehu264
[15] Mikhailidis DP, Elisaf M, Rizzo M, et al. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr Vasc Pharmacol, 2011; 9, 531-2. doi:  10.2174/157016111796642698
[16] Mikhailidis DP, Elisaf M, Rizzo M, et al. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr Vasc Pharmacol, 2011; 9, 533-71. doi:  10.2174/157016111796642661
[17] Gepner AD, Piper ME, Johnson HM, et al. Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial. Am Heart J, 2011; 161, 145-51. doi:  10.1016/j.ahj.2010.09.023
[18] Gossett LK, Johnson HM, Piper ME, et al. Smoking intensity and lipoprotein abnormalities in active smokers. J Clin Lipidol, 2009; 3, 372-8. doi:  10.1016/j.jacl.2009.10.008
[19] Beauchamp A, Tonkin A, Peeters A, et al. Associations among smoking status, lifestyle and lipoprotein subclasses. J Clin Lipidol, 2010; 4, 522-30. doi:  10.1016/j.jacl.2010.09.003
[20] Maeda K, Noguchi Y, Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: A meta-analysis. Prev Med, 2003; 37, 283-90. doi:  10.1016/S0091-7435(03)00110-5
[21] Vedanthan R, Seligman B, Fuster V, et al. Global perspective on acute coronary syndrome: a burden on the young and poor. Circ Res, 2014; 114, 1959-75. doi:  10.1161/CIRCRESAHA.114.302782
[22] Cotes JE, Chinn DJ. MRC questionnaire (MRCQ) on respiratory symptoms. Occup Med (Lond), 2007; 57, 388. doi:  10.1093/occmed/kqm051
[23] National health interview survey: adult tobacco use information. Centers for Disease Control and Prevention. https://www.cdc.govchshis/tobacco/tobacco_glossary.htm
[24] Xu RX, Zhang Y, Ye P, et al. Analysis of lipoprotein subfractions in Chinese Han patients with stable coronary artery disease. Heart Lung Circ, 2015; 24, 1203-10. doi:  10.1016/j.hlc.2015.05.002
[25] Superko HR, Pendyala L, Williams PT, et al. High-density lipoprotein subclasses and their relationship to cardiovascular disease. Lipidol, 2012; 6, 496-523. doi:  10.1016/j.jacl.2012.03.001
[26] Vandermeersch A, Ameye S, Puype D, et al. Estimation of the low-density lipoprotein (LDL) subclass phenotype using a direct, automated assay of small dense LDL-cholesterol without sample pretreatment. Clin Chim Acta, 2010; 411, 1361-6. doi:  10.1016/j.cca.2010.05.038
[27] Mackey RH, Mora S, Bertoni AG, et al. Lipoprotein particles and incident type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis. Diabetes Care, 2015; 38, 628-36.
[28] Zhang Y, Li S, Xu RX, et al. Distribution of high-density lipoprotein subfractions and hypertensive status: A cross-sectional study. Medicine, 2015; 94, e1912. doi:  10.1097/MD.0000000000001912
[29] Corsetti JP, Gansevoort RT, Sparks CE, et al. Inflammation reduces HDL protection against primary cardiac risk. Invest, 2010; 40, 483-9. http://www.ncbi.nlm.nih.gov/pubmed/20412290
[30] Imamura H, Teshima K, Miyamoto N, et al. Cigarette smoking, high-density lipoprotein cholesterol subfractions, and lecithin: Cholesterol acyltransferase in young women. Metabolism, 2002; 51, 1313-6. doi:  10.1053/meta.2002.34040
[31] Moffatt RJ, Chelland SA, Pecott DL, et al. Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C. Prev Med, 2004; 38, 637-41.32.Kontush A. HDL particle number and size as predictors of cardiovascular disease. Front Pharmacol, 2015; 6, 218. doi:  10.1016/j.ypmed.2003.12.002
[32] Kontush A. HDL particle number and size as predictors of cardiovascular disease. Front Pharmacol, 2015; 6, 218. doi:  10.3389/fphar.2015.00218/pdf